![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, April 21, 2014 12:18:44 PM
What is the market size for Levadopa-Induced Dyskinesia
Please Add to Shareholders Questions
Announced Positive Phase 2a Data for Eltoprozine in LID
What is the market size for Eltoprozine?
Established LymPro research collaboration with Boston University School of Medicine
What time lines have Boston University given on LymPro Research completion.
Announced positive Phase 2a Data for Eltoprazine in adult ADHD
Market Size for Eltoprazine in adult ADHD
Acquired exclusive option to license intellectual property for use of MANF and CDNF to treat Antibiotic-Induced Ototoxicity
Market size for MANF and CDNF to treat Antibiotic-Induced Ototoxicity
What other types of diagnosis treatments can be expeceted to be released for MANF in 2014 and how long to develop?
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM